ArticleMolecules (Basel, Switzerland)2022

Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain.

Lisa L Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.